SinoMab BioScience Limited (HKG:3681)
Hong Kong · Delayed Price · Currency is HKD 1.000
-0.015 (-1.48%)
Nov 3, 2026, 4:08 PM HKT
SinoMab BioScience Market Cap
SinoMab BioScience has a market cap or net worth of 1.39 billion as of November 2, 2026. It is the 21,260th most valuable company in the world and the 986th biggest in Hong Kong. Its market cap has decreased by 38.65% in one year.
Market Cap
1.39B
Enterprise Value
1.46B
Revenue
n/a
Global Rank
Country Rank
#986 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since November 12, 2019, SinoMab BioScience's market cap has decreased from 6.04B to 1.39B, a decrease of -77.03%. That is a compound annual growth rate of -19.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 1.39B | -25.37% |
| Dec 31, 2025 | 1.86B | 56.14% |
| Dec 31, 2024 | 1.19B | -31.56% |
| Dec 29, 2023 | 1.74B | -7.18% |
| Dec 30, 2022 | 1.87B | -34.91% |
| Dec 31, 2021 | 2.88B | -37.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AIM Vaccine | 1.88B |
| Mabpharm | 1.77B |
| Clover Biopharmaceuticals | 1.66B |
| Guangzhou Innogen Pharmaceutical Group | 1.50B |
| Beijing Biostar Pharmaceuticals | 1.44B |
| PegBio | 1.44B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.24B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.20B |